Selpercatinib
Products in Health Canada’s databases that list Selpercatinib as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 4
- 4 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 11
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| RETEVMO (40 MG) | 02516918 | Marketed | Eli Lilly Canada Inc | |
| RETEVMO (80 MG) | 02516926 | Marketed | Eli Lilly Canada Inc | |
| RETEVMO (80 MG) | 02565676 | Marketed | Eli Lilly Canada Inc | |
| RETEVMO (40 MG) | 02565668 | Approved | Eli Lilly Canada Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- RETEVMOFebruary 18, 2026 · NOC 36927
- RETEVMOFebruary 6, 2026 · NOC 36852
- RETEVMONovember 6, 2025 · NOC 36338
- RETEVMOJuly 22, 2025 · NOC 35703
- RETEVMOJanuary 10, 2025 · NOC 34669
- RETEVMOOctober 21, 2024 · NOC 34240
- RETEVMOJune 21, 2024 · NOC 33485
- RETEVMOOctober 19, 2023 · NOC 31890
- RETEVMOMarch 3, 2023 · NOC 30267
- RETEVMOApril 19, 2022 · NOC 27991
- RETEVMOJune 15, 2021 · NOC 26077